Cancer Treatment Costs Creating 'Financial Toxicity' for Patients

This article originally appeared here.
Share this content:
Cancer Treatment Costs Creating 'Financial Toxicity' for Patients
Cancer Treatment Costs Creating 'Financial Toxicity' for Patients

FRIDAY, Dec. 19, 2014 (HealthDay News) -- The cost of cancer treatment can cause financial stress that threatens patients' well-being, according to a new study published online Dec. 16 in the Journal of Oncology Practice.

Yousuf Zafar, M.D., associate professor at Duke University in Durham, N.C., and colleagues examined data from 1,000 people in the United States who had been diagnosed with colorectal or lung cancer. Of those patients, 889 had finished their treatments and were cancer-free, and 111 had advanced cancer. Nearly half of the patients (482) said they were struggling to pay their medical bills, which was linked with a poorer health-related quality of life.

This "financial toxicity" can impact cancer patients regardless of income, employment, or status of their cancer and other health problems, according to the researchers.

"Patients are at risk for not adhering to their treatments due to cost. They may have to borrow, spend their savings, or cut back on basics like food and clothing, all to help pay for care," Zafar explained in a university news release. "Financial toxicity is potentially harming our patients. Without a doubt, we have our patients' best interests in mind, so if we become more cognizant of that, we're more likely to act on it."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »